[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100441022":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":21,"responsibleParty":41,"collaborators":10,"id":44,"slug":10,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":45,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":10,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":63,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Azienda Ospedaliero-Universitaria Careggi","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"1",null,"Patients affected by biochemical relapse after radical prostatectomy undergoing staging PSMA-PET\u002FCT and baseline blood sample for miRNA panel assessment.",[13],{"name":14,"affiliation":5,"role":15},"Lorenzo Livi, Prof.","PRINCIPAL_INVESTIGATOR",[17],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","+390557947264","lorenzo.livi@unifi.it",[22],{"facility":23,"status":24,"city":25,"state":10,"zip":26,"country":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"AOU Careggi Radiation Oncology Unit","RECRUITING","Florence","50134","Italy",{"type":29,"coordinates":30},"Point",[31,32],11.24626,43.77925,{"lat":32,"lon":31},[35,37],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":36},"segr-radiotp@dfc.unifi.it",{"name":38,"role":18,"phone":39,"phoneExt":10,"email":40},"Giulio Francolini","3938576664","Francolinigiulio@gmail.com",{"type":15,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Lorenzo Livi","Full Professor","100441022",false,"NCT05022914","PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE","Prostate-Specific Membrane Antigen (PSMA) Guided Approach for bIoCHEmical Relapse After Prostatectomy- A Prospective Observational Study-PSICHE","PSICHE","Inclusion Criteria:\n\n* Signed informed consent\n* Age \\>18\n* Patient suitable for 68Ga-PSMA PET\u002FCT re-staging according to clinical practice (Previous radical prostatectomy with histological result of Prostate adenocarcinoma +\u002F- postoperative prostate bed radiotherapy (adjuvant or salvage setting), with a biochemical relapse defined as a PSA \\> 0.2 and \\\u003C1\n\nExclusion Criteria:\n\n* ADT administration within 6 months from study enrollment\n* Persistent elevation of PSA after RP measured within 16 weeks from surgery (\\> 0.1 ng\u002Fml)","MALE","18 Years",{"count":54,"type":55},180,"ESTIMATED","OBSERVATIONAL","This observational study was designed to evaluate progression free survival after PSMA-PET\u002FCT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.",[59,60,61,62],"Prostate Cancer","Biochemical Relapse Fo Malignant Neoplasm of Prostate","Prostate Adenocarcinoma","Prostate Cancer Recurrent",[64,65,66,67,68,69,70],"PSMA","68Ga-PSMA PET\u002FCT","PET\u002FCT","Biochemical Relapse","micro-RNA","SBRT","Radiotherapy","2021-08-24",{"date":73,"type":74},"2021-08-26","ACTUAL",{"date":76,"type":74},"2021-01-19",{"date":78,"type":55},"2027-01-19",{"name":5,"class":6},1]